Applikate Technologies

1:45 PM - 2:00 PM (PDT), Monday, June 13, 2022
Applikate's CHiMP pathology tissue processing and imaging platform eliminates the use of physical slides, revolutionizing the practice of pathology just as the digital camera changed photography. CHiMP turns a >16 hrs process with > 20 highly technical manual steps into a < 3 hr process that is completely automated. It produces direct-to-digital images from intact biopsy specimens with image quality superior even to the gold-standard physical slide, with fewer artifacts, in less time, with much less labor and for lower costs.

Applikate was spun out of Yale University by co-founders Dr. Michael Levene, an expert in optical microscopy, and Dr. Richard Torres, an anatomic pathologist. Dr. Eben Olson, who has worked with Drs. Levene and Torres for >15 years, rounds out the technical team. David Hunt, a serial entrepreneur with expertise in business, AI and intellectual property, joined the management team after leading the over-subscribed $2.6M Seed round in 2021.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
District Of Columbia  
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
The CHiMP pathology platform
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Applikate Technologies